Specialty Pharmacy

Dasatinib and demcizumab reduces lung adenocarcinomas and improves survival rates in lung cancer treatment.

Nanoparticle designed to directly hit tumors with a toxic cancerous drug without harming healthy tissue.

New HIV treatment approach scrambles DNA to stop it from multiplying.

Gut microbiota poses a curious question in MS development and research.

Pharmacists can play a role in a comprehensive geriatric assessment and transitional care bridge program to improve outcomes for older adults.

Palbociclib (Ibrance) approved for hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced or metastatic breast cancer.

Ibrance approved for the treatment of HR+, HER2- advanced or metastatic breast cancer.

Elamipretide targets the inner mitochondrial membrane and helps preserve mitochondrial energetics in patients with primary mitochondrial myopathy.

Antibody-drug conjugates and immunotherapy harness immune system to target breast cancer tumors.

Hysterectomies can reduce the risk for ovarian cancer but it can lead to surgical menopause.

Researchers explore possible reasons why HIV-positive patients have a decreased risk of MS.

Treatments approved for heart failure, cardiac arrhythmia, and infections offer epigenetic effects in cancer therapy.

Most read articles of the week on The American Journal of Pharmacy Benefits.

Top news of the week in oncology medication development.

Most MS patients have not considered changing their diet as a therapeutic approach.

Patient Action Plan can improve treatment across a variety of disease states in specialty pharmacy.

Catch up with the latest developments across the health care landscape and sign up for key upcoming conferences.

Research compares different methods to control the symptoms of MS.

A summary of the clinical potential of biosimilar therapies and special considerations for older patients with cancer.

Analysts believe T-cell therapies must first show curative properties in blood cancer treatment to justify the cost.

Most read articles of the week on Specialty Pharmacy Times.

Discovery holds promise for treatment of cirrhosis and liver damage related to hepatitis C.

HIV protein can impair neurocognitive function in nearly half of HIV-positive patients.

Research seeks to to prevent the onset of an aggressive form of rheumatoid arthritis

Pharmacists should engage patients in interactive conversations in order to ensure they take medications as directed.

Phase 2 trial shows reduction in the cumulative total number of gadolinium-enhancing lesions in MS patients.

Diabetes and other conditions are also influenced by a person’s height.

Antiretroviral therapy taken early and frequently can limit the spread of HIV.